Pharmaceutical
| Tue 21 Apr 2026
Alexandria, April 21 -- NMD Pharma has submitted a patent application for Compositions and Methods for Treating Myasthenia Gravis. This invention was developed by Pedersen Thomas Holm, Hutchison John Blundell, Nielsen Ole Baekgaard, Knutsen Lars J S, Nordholm Lars, Kelly Nicholas Michael, Chin Eva Rose, Jensen Klaus Gjervig, Fla..